This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MedTech Summit

REGISTRATION CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
10 - 14 June 2024
DoubleTree by Hilton Brussels CityBrussels, Belgium (Hybrid Event)

Stephanie Seidel
Senior Principal Regulatory Affairs Specialist, Robotic Surgical Technologies (RST) at Medtronic
Speaker

Profile

Stephanie Seidel has over 20 years of medical device experience. She has over 16 years in regulatory affairs, including over 8 years in regulatory leadership roles, and 3 in clinical research working on hybrid regulatory/clinical projects with global reach.

As a senior regulatory leader, she and her teams strategized and implemented successful regulatory strategies in over 90 global markets. Stephanie has authored or collaborated on 150+ approved US and international regulatory submissions for devices in Classes I through III, including implantables and novel devices. Stephanie has broad technical expertise, with multi-product active and passive implantable systems, software, wireless devices, surgical tools, electromechanical hardware, and combination drug/device and device/biologic products. Device expertise includes cochlear implant systems, endovascular intervention devices, neuromodulation systems and blood processing devices.

Stephanie has been developing and collaborating on global clinical evidence strategies for over 10 years. Recently, she has distinguished herself as a senior clinical evaluation strategist and author for the EU MDR, China and other global markets. She volunteers on many community-building projects within Medtronic and for RAPS to serve the regulatory affairs community. Currently, Stephanie is a Sr Principal Clinical Evaluation Specialist with Medtronic Peripheral Vascular Health.

Agenda Sessions

  • Supporting Indirect Clinical Benefits in Clinical Evaluations

    14:15